Opyl Limited (ASX:OPL)
Opyl Limited s a new generation Australian company. The Company provides biopharma and health organizations access to emerging artificial intelligence (AI)-assisted technologies and guidance to understand and improve healthcare design, development and delivery. The Company is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The Company has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The Company is also developing Clinical trial prediction and protocol design tool. The Company subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.